IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
200.04
+0.93 (0.47%)
Feb 4, 2025, 4:00 PM EST - Market closed
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $3.90B in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to $15.32B, up 3.10% year-over-year. In the year 2023, IQVIA Holdings had annual revenue of $14.98B with 3.98% growth.
Revenue (ttm)
$15.32B
Revenue Growth
+3.10%
P/S Ratio
2.38
Revenue / Employee
$176,034
Employees
87,000
Market Cap
36.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
IQV News
- 16 hours ago - IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year - Business Wire
- 14 days ago - IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025 - Business Wire
- 22 days ago - IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions - Business Wire
- 6 weeks ago - Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute - Business Wire
- 7 weeks ago - IQVIA Holdings: Share Price Disconnected From Growth Outlook - Seeking Alpha
- 3 months ago - IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 - Business Wire
- 3 months ago - IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - IQVIA lowers annual revenue forecast amid trial delays - Reuters